Navigation Links
PDL BioPharma Announces Pricing of $300,000,000 Securitization Transaction
Date:10/28/2009

ion to pay a special cash dividend to stockholders. The total amount of the special dividend, together with the record and payment dates, will be decided by the Company's Board of Directors at its upcoming meeting on November 11, 2009 and will be announced the following day. The amount of the special dividend on a per share basis will be announced on the record date. PDL expects to pay the special dividend in 2009.

The Notes have not been and will not be registered under the Securities Act of 1933, as amended (the "Securities Act"), or under any applicable state securities laws and may not be offered or sold in the United States or to U.S. persons unless the Notes are registered under the Securities Act or an exemption from the registration requirements of the Securities Act is available. Accordingly, the Notes have been initially offered and sold only to "qualified institutional buyers" under Rule 144A under the Securities Act and to "institutional accredited investors" under Rule 501(a)(1), (2), (3) or (7) under the Securities Act who are non-U.S. persons in offshore transactions under Regulation S under the Securities Act.

This press release is neither an offer to sell nor the solicitation of an offer to buy the Notes or any other securities and shall not constitute an offer, solicitation or sale in any jurisdiction in which, or to any persons to whom, such an offer, solicitation or sale is unlawful. This press release is being issued pursuant to and in accordance with Rule 135c under the Securities Act.

About PDL BioPharma

PDL pioneered the humanization of monoclonal antibodies and, by doing so, enabled the discovery of a new generation of targeted treatments for cancer and immunologic diseases. PDL is focused on maximizing the value of its antibody humanization patents and related assets. The company receives royalties on sales of a number of humanized antibody products marketed today and also may receive
'/>"/>

SOURCE PDL BioPharma, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
2. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
3. PDL BioPharma Announces Internal CEO Investigation Found No Credible Evidence of Improper Personal Conduct or Breach of Fiduciary Duty
4. Nabi Biopharmaceuticals to Present at Upcoming Industry Conferences
5. PDL BioPharma Announces Significant Strategic and Portfolio Changes to Focus on Antibody Discovery and Development
6. XTL Biopharmaceuticals Announces Presentation of Novel Pre-Clinical Inhibitors of Hepatitis C at an Upcoming International Scientific Conference
7. XTL Biopharmaceuticals Initiates Phase IIb Clinical Trial of Bicifadine for the Treatment of Diabetic Neuropathic Pain
8. Nabi Biopharmaceuticals Announces Sale of Nabi Biologics to Biotest AG
9. Keryx Biopharmaceuticals to Present at Bank of America Investment Conference
10. Morria Biopharmaceuticals Plc Announces Appointment of Dr. Rosemary Mazanet as Interim Chief Executive Officer
11. Keryx Biopharmaceuticals, Inc. Announces Appointment of Michael P. Tarnok to Board of Directors

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/18/2009)..., Security personnel need to be able to find exp...act with them. To aid such searches, the National ... support from the Department of Homeland Security,... Standard Reference Material (SRM) 2905, Trace Par...oratory assay methods, the SRM will be helpful in ...
(Date:11/18/2009)...Scientists at Queen,s University Belfast are devel...legal drugs which will help in the fight against t...ll use special gel pads to ,swipe, an individual o...lysed by a scanning instrument that can detect the...llow better, faster decisions to be made in respon...
(Date:11/18/2009)..., , Vernier,s experience in data analysis ... (TM) program kits and curricula provide s...on ,, BEAVERTON, Ore., Nov. 18 /PRNewswire/ -... educational science interfaces, sensors, and soft...al manufacturer and distributor of life science re...
(Date:11/18/2009)..., , EAST GRINSTEAD, West Sussex, U.K. and CLE...stems, a Magellan Biosciences business and premier... products for microbiology labs, has expanded its ...nd development facility to meet increasing global ...usceptibility and identification testing. The expa...
Breaking Biology Technology:New NIST trace explosives standard slated for homeland security duty 2New technology detects chemical weapons in seconds 2Vernier and Bio-Rad to Offer Enhanced Solutions for Biotechnology Education 2TREK Diagnostic Systems Opens New U.K. Facility in East Grinstead to Meet Expanded Customer Demand for Microbiology Products 2TREK Diagnostic Systems Opens New U.K. Facility in East Grinstead to Meet Expanded Customer Demand for Microbiology Products 3TREK Diagnostic Systems Opens New U.K. Facility in East Grinstead to Meet Expanded Customer Demand for Microbiology Products 4
...l Shows Disease Progression Can Be Prevented, BER...e in the December issue of The European Journal of...s report the results of,studies made possible unde...R). In the article entitled, "Treatment of lupus-p...eads to reduction of autoantibody production,and a...
...l., Nov. 26 Archer Daniels Midland,Company (NYSE:...ive vice,president, has elected to retire by year ...gnment to advance the,Company,s business strategy ...y work now transitions to the Company,s strategic ... senior vice president, Strategic,Planning. John R...
...address significant unmet medical needs in cancer ...W YORK, Nov. 26 China Aoxing Pharmaceutical,Compa... largest,manufacturing facility and product pipeli...n medication in China, today announced that the Ch...d the Company the designated,manufacturer status t...
Other Biology Technology:Dynavax Reports Progress in Lupus Program With Inhibitor of TLR7 and TLR9 2Dynavax Reports Progress in Lupus Program With Inhibitor of TLR7 and TLR9 3ADM Executive Vice President Bill Camp to Retire 2China Aoxing Pharmaceutical Designated as a Key Manufacturer of Cancer Pain Drug by China SFDA 2China Aoxing Pharmaceutical Designated as a Key Manufacturer of Cancer Pain Drug by China SFDA 3China Aoxing Pharmaceutical Designated as a Key Manufacturer of Cancer Pain Drug by China SFDA 4
(Date:11/22/2009)...at the Brain Research Centre, a partnership of the...e and Vancouver Coastal Health Research Institute,...m by which brain cells die following a stroke, as ...e results of the study were recently published onl...many brain cells continue to die even after blood ...
(Date:11/20/2009)...Mich.---We,ve all read studies about the health be... true at the molecular level, where amino acids kn...e when single than when paired up with other cyste...chigan, along with colleagues in Belgium, have dis...gle cysteines. The research appears in the Nov. 20...
(Date:11/20/2009)...on, DC Nov. 20, 2009) Scientists from the Marine...ns of the Naval Research Laboratory (NRL) organize...ntists on an Arctic expedition to initiate methane...mine the spatial variation of sediment contributio... Coast Guard Cutter Polar Sea as a research platfo...
Breaking Biology News(10 mins):New understanding about mechanism for cell death after stroke leads to possible therapy 2Saving the single cysteine: New antioxidant system found 2International expedition investigates climate change, alternative fuels in Arctic 2American Lung Association in Florida Joins Anti Recession Campaign by Forming Strategic Alliance With www i am anti recession com 54664 1American Lung Association in Florida Joins Anti Recession Campaign by Forming Strategic Alliance With www i am anti recession com 54664 2Study shows how to boost value of Alzheimers fighting compounds 54660 1Study shows how to boost value of Alzheimers fighting compounds 54660 2Researcher says microchannels could advance tissue engineering methods 9601 1Researcher says microchannels could advance tissue engineering methods 9601 2Researcher says microchannels could advance tissue engineering methods 9601 3Researcher says microchannels could advance tissue engineering methods 9601 4
... acute ischemic stroke, the blood supply to the br... lack of oxygen. In addition, ischemia activates h... of the brain. For the first time, scientists at t...tal have shown that certain immune cells in the bl...ls are known as regulatory T lymphocytes (Treg). T...
...ivate companies, universities and government agenc...h into the era of "cloud computing," the name for ...e Internet., The University of Washington has won...ndation related to cloud computing. Two of the gra...ulations and analyzing astronomical images. Both p...
...rotenoids have important physiological functions, ...protectant properties. Carotenoid pigments are als...responsible for most of their red, orange and yell...ation in birds has been shown to act as an ornamen...the individual and its ability to locate high qual...
Other Biology News:'First aid' for brain cells comes from blood 2Harnessing cloud computing for data-intensive research on oceans, galaxies 2Harnessing cloud computing for data-intensive research on oceans, galaxies 3
Goat Anti-DRAK 2 Polyclonal Antibody, Unconjugated from Novus Biologicals
Rabbit Anti-Human Secretory Carrier Membrane Protein 2 (SCAMP2) Polyclonal Antibody, Unconjugated from Lifespan Biosciences
...tain a proprietary high-performance desalting resi...salting and protein-recovery characteristics compa...s containing as low as 25 g/ml of protein can be p...nd > 95% retention of salts and other small molecu...
... antibody detects an ~185 kDa protein, correspondi...orylated at tyrosine 1248 on SDS-PAGE immunoblots....rbed against the non-phosphorylated peptide to rem...ted form of the protein. In cell lines where EGFR...
Biology Products: